Test to Detect Spread of Breast Cancer Approved
FDA yesterday approved the first molecular diagnostic test that can detect the spread of breast cancer to the lymph nodes. If breast cancer cells are found in the lymph nodes, that's a strong indicator that the cancer has spread there and the patient's treatment should be changed. The GeneSearch BLN Assay, made by Veridex (Warren, NJ), a Johnson & Johnson company, produces results in 40 minutes and is faster and more accurate than existing tests.
July 17, 2007
FDA yesterday approved the first molecular diagnostic test that can detect the spread of breast cancer to the lymph nodes. If breast cancer cells are found in the lymph nodes, that's a strong indicator that the cancer has spread there and the patient's treatment should be changed. The GeneSearch BLN Assay, made by Veridex (Warren, NJ), a Johnson & Johnson company, produces results in 40 minutes and is faster and more accurate than existing tests.
You May Also Like